InvestorsHub Logo
Followers 8
Posts 1891
Boards Moderated 0
Alias Born 05/05/2016

Re: DewDiligence post# 35750

Monday, 09/25/2017 9:24:16 PM

Monday, September 25, 2017 9:24:16 PM

Post# of 108192

ADXS had better get moving with NEO.

You seem to think/imply that this is bad news!
I think quite the opposite, it's building momentum in
an area where ADXS has it's core competency.


<GNCA> announced a strategic shift to immuno-oncology and a focus on the development of neoantigen cancer vaccines,

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ADXS News